Help us: Donate
Follow us on:
×

Menu

Back

Tag: Press Release

Mebots
The pandemic has pushed many people indoors, and for many people, this has meant more time watching TV or using the computer. Screen time is now an average of 7 hours per day, which has led to all-time highs of obesity, worsening health, anxiety, and depression. There's a global health crisis, and Forever Today is...
Researchers from the University of Connecticut, Stanford University, Université Laval Quebec, and NSU Florida have helped test large-scale exogenous mitochondrial transplants in animal disease models and in-vitro human cells. The results suggest broad efficacy for targeting the immune system, brain, retina, liver, skin, and systemic anti-aging. This is the first time that a mitochondrial transplant...
Rejuveron Press Release
Rejuveron Life Sciences AG (‘Rejuveron’), a Zürich-based biotechnology company developing therapies to promote healthy aging, is pleased to announce that the first participant has been treated in Endogena Therapeutics’ phase 1/2a clinical study of its lead product, EA-2353, a photoreceptor regeneration treatment for retinitis pigmentosa (RP). See Endogena’s full press release here. Rejuveron has a near-majority...
Switzerland, Jun 30, 2022 - Molecule, a comprehensive funding and incubation ecosystem for early-stage biopharma research, announced this week they raised $12.7 million in seed funding. The round was led by Northpond Ventures with participation from Shine Capital, 1kx, Fifty Years, KdT Ventures, BACKED VC, Inflection VC, Chris Leiter, Balaji Srinivasan, Zee Prime Capital, The...
THC logo
A novel cryptocurrency, Transhuman Coin, has recently announced its debut. When a transaction occurs, this coin is automatically distributed back into funding its own growth and the development of research into cures for various disabilities, including age-related disorders. We at Lifespan.io support Transhuman Coin donations on our donations page, and THC has donated 10 million...
Longevity Investors Conference is an investors only event focused on investing in rejuvenation biotechnology.
Press Release The second investors only conference focusing on Longevity will take place on the 27th of September 2021 Zug, 24. August 2021 - The Longevity Investors Conference targets the global investor community and brings private and institutional investors from (U)HNWIs, Family Offices, VCs, Private Equity Funds, Private Banks and Asset Managers together with top...